Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Gross Margin (2024 - 2025)

Autolus Therapeutics' Gross Margin history spans 2 years, with the latest figure at 4.29% for Q4 2025.

  • For Q4 2025, Gross Margin rose 3916123.0% year-over-year to 4.29%; the TTM value through Dec 2025 reached 27.83%, down 1541.0%, while the annual FY2025 figure was 27.83%, 1531.0% down from the prior year.
  • Gross Margin reached 4.29% in Q4 2025 per AUTL's latest filing, up from 35.15% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q1 2024 to a low of 39165.52% in Q4 2024.